HedgeChatter

  • Home /
  • Tag Archives

MACK

Nasdaq stocks posting largest percentage increases

[AP] – A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: InterCloud Systems rose 22.9 percent to $12.90. Bind Therapeutics rose 12.0 percent to $15.40. RiceBran Tech rose 10.6 percent … moreView todays social media effects on MACKView the latest stocks trending across Twitter. Click to view dashboardSee who Merrimack is hiring next, click […]

May 12, 2014 Bystocknews , Comments Off on Nasdaq stocks posting largest percentage increases read more

Merrimack Pharmaceuticals to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

[GlobeNewswire] – CAMBRIDGE, Mass. — Merrimack Pharmaceuticals, Inc. today announced that Ulrik Nielsen, Chief Scientific Officer, is scheduled to present at the Bank of America Merrill Lynch 2014 Health Care Conference … moreView todays social media effects on MACKView the latest stocks trending across Twitter. Click to view dashboardSee who Merrimack is hiring next, click here to view […]

May 7, 2014 Bystocknews , Comments Off on Merrimack Pharmaceuticals to Present at the Bank of America Merrill Lynch 2014 Health Care Conference read more

Merrimack Pharmaceuticals: The Long Case

moreView todays social media effects on MACKView the latest stocks trending across Twitter. Click to view dashboardSee who Merrimack is hiring next, click here to view […]

May 6, 2014 Bystocknews , Comments Off on Merrimack Pharmaceuticals: The Long Case read more

8:02 am Merrimack Pharma announced Phase 1 results from a clinical pilot study demonstrating that ferumoxytol, an iron oxide nanoparticle, was well tolerated when used as a tumor contrast agent prior to MM-398 treatment.

moreView todays social media effects on MACKView the latest stocks trending across Twitter. Click to view dashboardSee who Merrimack is hiring next, click here to view […]

April 9, 2014 Bystocknews , Comments Off on 8:02 am Merrimack Pharma announced Phase 1 results from a clinical pilot study demonstrating that ferumoxytol, an iron oxide nanoparticle, was well tolerated when used as a tumor contrast agent prior to MM-398 treatment. read more

Merrimack Provides Fourth Quarter and Full Year 2013 Financial Results

[GlobeNewswire] – CAMBRIDGE, Mass. — Merrimack Pharmaceuticals, Inc. , a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment … moreView todays social media effects on MACKView the latest stocks trending across Twitter. Click to view dashboardSee who Merrimack is hiring next, click here to view […]

February 27, 2014 Bystocknews , Comments Off on Merrimack Provides Fourth Quarter and Full Year 2013 Financial Results read more

Merrimack to Present at the Cowen and Company 34th Annual Health Care Conference

[GlobeNewswire] – CAMBRIDGE, Mass. — Merrimack Pharmaceuticals, Inc. today announced that Ulrik Nielsen, Chief Scientific Officer, is scheduled to present at the Cowen and Company 34th Annual Health Care Conference on … moreView todays social media effects on MACKView the latest stocks trending across Twitter. Click to view dashboardSee who Merrimack is hiring next, click here to view […]

February 24, 2014 Bystocknews , Comments Off on Merrimack to Present at the Cowen and Company 34th Annual Health Care Conference read more

Merrimack Announces Timing of Fourth Quarter 2013 Investor Conference Call

[GlobeNewswire] – CAMBRIDGE, Mass. — Merrimack Pharmaceuticals, Inc. today announced that the company will host its Fourth Quarter 2013 Investor Conference Call and webcast at 4:30 p.m., Eastern time, on Thursday, February … moreView todays social media effects on MACKView the latest stocks trending across Twitter. Click to view dashboardSee who Merrimack is hiring next, click here to view […]

February 20, 2014 Bystocknews , Comments Off on Merrimack Announces Timing of Fourth Quarter 2013 Investor Conference Call read more